Quest Diagnostics announced Monday that it launched the first direct-to-consumer blood test to help people assess their risk of developing Alzheimer's disease.
Cognition Therapeutics President and CEO Lisa Ricciardi discusses the FDA considering the approval of a new Alzheimer's drug and the progress being made in the space to help combat the disease.
Quest Diagnostics on Monday released the first blood test for consumer purchase that can help assess the risk of developingThe AD-Detect Test for Alzheimer's Disease costs $399 and is available for purchase online and can assess a person's risk based on a brain protein that contributes to the condition, according to Quest.
Quest said its screening test uses plasma from a single blood draw to evaluate levels of amyloid beta proteins – which can form plaques in the brain and are linked to the progression of Alzheimer's disease – to help detect early signs associated with the risk of developing the disease.The innovation comes as the landscape for Alzheimer's disease care rapidly changes with new and emerging therapies.
"We are seeing much attention on emerging therapies for Alzheimer's disease, but with new treatment options will come the need to make screening and diagnosis more widely available," said Dr. Michael Racke, medical director of neurology for Quest Diagnostics. Dr. Seth Gale points out evidence of Alzheimer’s disease on an MRI at the Center for Alzheimer Research and Treatment at Brigham And Women’s Hospital in Boston, Massachusetts, on March 30, 2023.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Quest Diagnostics launches Alzheimer's blood test for consumersQuest Diagnostics on Monday launched the first direct-to-consumer blood test to detect abnormal levels of beta amyloid, a key Alzheimer's protein which can appear years before dementia symptoms arise.
Read more »
Quest Diagnostics launches Alzheimer's blood test for consumersQuest Diagnostics on Monday launched the first direct-to-consumer blood test to detect abnormal levels of beta amyloid, a key Alzheimer's protein which can appear years before dementia symptoms arise.
Read more »
Lady Gaga Mourns 'Painful' But 'Beautiful' Loss of Tony BennettLady Gaga is reflecting on her late friend and collaborator Tony Bennett in a touching tribute.
Read more »
N.J. has 6th highest rate of Alzheimer’s among seniors in nation, study findsAn estimated 185,000 New Jersey residents have Alzheimer's disease, a brain disorder that slowly destroys memory, thought and language.
Read more »
Texas Alzheimer’s patient calls new treatment life-changingThese past few years are being called a major tipping point in Alzheimer's research. A second treatment has now been approved that targets the underlying cause of Alzheimer's, not just the symptoms.
Read more »